{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:48:07Z","timestamp":1792702087115,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["23H02693"],"award-info":[{"award-number":["23H02693"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12185-024-03781-5","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T01:01:45Z","timestamp":1716858105000},"page":"331-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-858X","authenticated-orcid":false,"given":"Kennosuke","family":"Karube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"3781_CR1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5 th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia."},{"key":"3781_CR2","volume-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues, revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues, revised. 4th ed. Lyon: IARC Press; 2017.","edition":"4"},{"key":"3781_CR3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood"},{"key":"3781_CR4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 1994;84:1361\u201392.","journal-title":"Blood"},{"key":"3781_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18940","author":"B Falini","year":"2023","unstructured":"Falini B, Lazzi S, Pileri S. A comparison of the international consensus and 5th WHO classifications of T-cell lymphomas and histiocytic\/dendritic cell tumours. Br J Haematol. 2023. https:\/\/doi.org\/10.1111\/bjh.18940.","journal-title":"Br J Haematol."},{"key":"3781_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41375-022-01764-1","volume":"37","author":"B Falini","year":"2023","unstructured":"Falini B, Martino G, Lazzi S. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. Leukemia. 2023;37:18\u201334.","journal-title":"Leukemia"},{"key":"3781_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","volume":"480","author":"V Vela","year":"2022","unstructured":"Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch. 2022;480:403\u201313.","journal-title":"Virchows Arch"},{"key":"3781_CR8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","volume":"26","author":"I Brenner","year":"2013","unstructured":"Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol. 2013;26:1568\u201376.","journal-title":"Mod Pathol"},{"key":"3781_CR9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","volume":"201","author":"RJ Bende","year":"2005","unstructured":"Bende RJ, Aarts WM, Riedl RG, de Jong D, Pals ST, van Noesel CJ. Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med. 2005;201:1229\u201341.","journal-title":"J Exp Med"},{"key":"3781_CR10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","volume":"138","author":"K Maurus","year":"2018","unstructured":"Maurus K, Appenzeller S, Roth S, et al. Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J Invest Dermatol. 2018;138:1573\u201381.","journal-title":"J Invest Dermatol"},{"key":"3781_CR11","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","volume":"34","author":"JT Edinger","year":"2010","unstructured":"Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010;34:1830\u201341.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2302\/kjm.48.22","volume":"48","author":"JW Streilein","year":"1999","unstructured":"Streilein JW, Alard P, Niizeki H. A new concept of skin-associated lymphoid tissue (SALT): UVB light impaired cutaneous immunity reveals a prominent role for cutaneous nerves. Keio J Med. 1999;48:22\u20137.","journal-title":"Keio J Med"},{"key":"3781_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","volume":"99","author":"U Randen","year":"2014","unstructured":"Randen U, Troen G, Tierens A, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014;99:497\u2013504.","journal-title":"Haematologica"},{"key":"3781_CR14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/bloodadvances.2020001608","volume":"4","author":"A Malecka","year":"2020","unstructured":"Malecka A, Delabie J, Ostlie I, et al. Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18. Blood Adv. 2020;4:993\u20136.","journal-title":"Blood Adv"},{"key":"3781_CR15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.15063","volume":"183","author":"A Malecka","year":"2018","unstructured":"Malecka A, Troen G, Tierens A, et al. Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease. Br J Haematol. 2018;183:838\u201342.","journal-title":"Br J Haematol"},{"key":"3781_CR16","first-page":"339","volume":"87","author":"V Ascoli","year":"2002","unstructured":"Ascoli V, Lo Coco F, Torelli G, et al. Human herpesvirus 8-associated primary effusion lymphoma in HIV\u2013patients: a clinicopidemiologic variant resembling classic Kaposi\u2019s sarcoma. Haematologica. 2002;87:339\u201343.","journal-title":"Haematologica"},{"key":"3781_CR17","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/bloodadvances.2020002293","volume":"4","author":"D Kaji","year":"2020","unstructured":"Kaji D, Ota Y, Sato Y, et al. Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020;4:4442\u201350.","journal-title":"Blood Adv"},{"key":"3781_CR18","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1182\/blood-2003-03-0692","volume":"102","author":"T Marafioti","year":"2003","unstructured":"Marafioti T, Jones M, Facchetti F, et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood. 2003;102:2868\u201376.","journal-title":"Blood"},{"key":"3781_CR19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1411\u201321.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","volume":"137","author":"C Sarkozy","year":"2021","unstructured":"Sarkozy C, Hung SS, Chavez EA, et al. Mutational landscape of gray zone lymphoma. Blood. 2021;137:1765\u201376.","journal-title":"Blood"},{"key":"3781_CR21","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020\u20138.","journal-title":"Blood"},{"key":"3781_CR22","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","volume":"23","author":"R Fonseca","year":"2009","unstructured":"Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210\u201321.","journal-title":"Leukemia"},{"key":"3781_CR23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","volume":"125","author":"J Corre","year":"2015","unstructured":"Corre J, Munshi N, Avet-Loiseau H. Genetics of multiple myeloma: another heterogeneity level? Blood. 2015;125:1870\u20136.","journal-title":"Blood"},{"key":"3781_CR24","volume-title":"world health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris N, et al. world health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.","edition":"4"},{"key":"3781_CR25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440\u20132.","journal-title":"Nature"},{"key":"3781_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","volume":"348","author":"A Strasser","year":"1990","unstructured":"Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990;348:331\u20133.","journal-title":"Nature"},{"key":"3781_CR27","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","volume":"114","author":"NA Johnson","year":"2009","unstructured":"Johnson NA, Savage KJ, Ludkovski O, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273\u20139.","journal-title":"Blood"},{"key":"3781_CR28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","volume":"23","author":"N Niitsu","year":"2009","unstructured":"Niitsu N, Okamoto M, Miura I, Hirano M. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations. Leukemia. 2009;23:777\u201383.","journal-title":"Leukemia"},{"key":"3781_CR29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","volume":"41","author":"EM Moore","year":"2017","unstructured":"Moore EM, Aggarwal N, Surti U, Swerdlow SH. Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology. Am J Surg Pathol. 2017;41:1155\u201366.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2559.2012.04301.x","volume":"61","author":"R Kanagal-Shamanna","year":"2012","unstructured":"Kanagal-Shamanna R, Medeiros LJ, Lu G, et al. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and\/or MYC gene rearrangements and a poor prognosis. Histopathology. 2012;61:945\u201354.","journal-title":"Histopathology"},{"key":"3781_CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","volume":"37","author":"RK Pillai","year":"2013","unstructured":"Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol. 2013;37:323\u201332.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR32","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","volume":"7","author":"Q Ye","year":"2016","unstructured":"Ye Q, Xu-Monette ZY, Tzankov A, et al. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Oncotarget. 2016;7:2401\u201316.","journal-title":"Oncotarget"},{"key":"3781_CR33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","volume":"34","author":"F Cucco","year":"2020","unstructured":"Cucco F, Barrans S, Sha C, et al. Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit. Leukemia. 2020;34:1329\u201341.","journal-title":"Leukemia"},{"key":"3781_CR34","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","volume":"19","author":"Y Guo","year":"2005","unstructured":"Guo Y, Karube K, Kawano R, et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia. 2005;19:1058\u201363.","journal-title":"Leukemia"},{"key":"3781_CR35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","volume":"27","author":"K Koch","year":"2016","unstructured":"Koch K, Hoster E, Ziepert M, et al. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol. 2016;27:1323\u20139.","journal-title":"Ann Oncol"},{"key":"3781_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.11.002","volume":"72","author":"R El Behery","year":"2018","unstructured":"El Behery R, Laurini JA, Weisenburger DD, et al. Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma. Hum Pathol. 2018;72:180\u201390.","journal-title":"Hum Pathol"},{"key":"3781_CR37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","volume":"45","author":"C Laurent","year":"2021","unstructured":"Laurent C, Adelaide J, Guille A, et al. High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B. Am J Surg Pathol. 2021;45:1324\u201336.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ejh.13082","volume":"101","author":"A Meister","year":"2018","unstructured":"Meister A, Hentrich M, Wyen C, Hubel K. Malignant lymphoma in the HIV-positive patient. Eur J Haematol. 2018;101:119\u201326.","journal-title":"Eur J Haematol"},{"key":"3781_CR39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","volume":"99","author":"Y Shimoyama","year":"2008","unstructured":"Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008;99:1085\u201391.","journal-title":"Cancer Sci"},{"key":"3781_CR40","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","volume":"132","author":"Y Natkunam","year":"2018","unstructured":"Natkunam Y, Gratzinger D, Chadburn A, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018;132:1871\u20138.","journal-title":"Blood"},{"key":"3781_CR41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/cei.12851","volume":"187","author":"AR Masters","year":"2017","unstructured":"Masters AR, Haynes L, Su DM, Palmer DB. Immune senescence: significance of the stromal microenvironment. Clin Exp Immunol. 2017;187:6\u201315.","journal-title":"Clin Exp Immunol"},{"key":"3781_CR42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/leu.2013.348","volume":"28","author":"W Kraan","year":"2014","unstructured":"Kraan W, van Keimpema M, Horlings HM, et al. High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma. Leukemia. 2014;28:719\u201320.","journal-title":"Leukemia"},{"key":"3781_CR43","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378:1396\u2013407.","journal-title":"N Engl J Med"},{"key":"3781_CR44","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood.2020006338","volume":"137","author":"DDW Twa","year":"2021","unstructured":"Twa DDW, Lee DG, Tan KL, et al. Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma. Blood. 2021;137:1256\u20139.","journal-title":"Blood"},{"key":"3781_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.04.002","volume":"72","author":"J Hori","year":"2019","unstructured":"Hori J, Yamaguchi T, Keino H, Hamrah P, Maruyama K. Immune privilege in corneal transplantation. Prog Retin Eye Res. 2019;72: 100758.","journal-title":"Prog Retin Eye Res"},{"key":"3781_CR46","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1158\/1078-0432.CCR-05-2617","volume":"12","author":"M Booman","year":"2006","unstructured":"Booman M, Douwes J, Glas AM, et al. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma. Clin Cancer Res. 2006;12:2698\u2013705.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"3781_CR47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229.","journal-title":"Blood."},{"key":"3781_CR48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","volume":"55","author":"W Xiao","year":"2016","unstructured":"Xiao W, Chen WW, Sorbara L, et al. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol. 2016;55:108\u201316.","journal-title":"Hum Pathol"},{"key":"3781_CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3960\/jslrt.22046","volume":"63","author":"AM Maeshima","year":"2023","unstructured":"Maeshima AM. Histologic transformation of follicular lymphoma: pathologists\u2019 viewpoint. J Clin Exp Hematop. 2023;63:12\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"3781_CR50","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","volume":"210","author":"G Fabbri","year":"2013","unstructured":"Fabbri G, Khiabanian H, Holmes AB, et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to richter syndrome. J Exp Med. 2013;210:2273\u201388.","journal-title":"J Exp Med"},{"key":"3781_CR51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.14700","volume":"178","author":"TA Eyre","year":"2017","unstructured":"Eyre TA, Schuh A. An update for richter syndrome\u2014new directions and developments. Br J Haematol. 2017;178:508\u201320.","journal-title":"Br J Haematol"},{"key":"3781_CR52","doi-asserted-by":"crossref","first-page":"8864","DOI":"10.1002\/cam4.3501","volume":"9","author":"T Shichijo","year":"2020","unstructured":"Shichijo T, Maruyama D, Yamauchi N, et al. Transformation scoring system (TSS): a new assessment index for clinical transformation of follicular lymphoma. Cancer Med. 2020;9:8864\u201374.","journal-title":"Cancer Med"},{"key":"3781_CR53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bjh.14153","volume":"174","author":"AM Maeshima","year":"2016","unstructured":"Maeshima AM, Taniguchi H, Toyoda K, et al. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol. 2016;174:923\u201331.","journal-title":"Br J Haematol"},{"key":"3781_CR54","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","volume":"117","author":"G Gutierrez-Garcia","year":"2011","unstructured":"Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood. 2011;117:4836\u201343.","journal-title":"Blood"},{"key":"3781_CR55","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000001691","volume":"45","author":"K Morichika","year":"2021","unstructured":"Morichika K, Karube K, Sakihama S, et al. The positivity of phosphorylated STAT3 Is a novel marker for favorable prognosis in germinal center B-cell type of diffuse large B-cell lymphoma. Am J Surg Pathol. 2021;45:832\u201340.","journal-title":"Am J Surg Pathol"},{"key":"3781_CR56","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdq627","volume":"22","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki K, Yamaguchi M, Suzuki R, et al. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011;22:1601\u20137.","journal-title":"Ann Oncol"},{"key":"3781_CR57","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO.2016.70.3660","volume":"35","author":"AM Staiger","year":"2017","unstructured":"Staiger AM, Ziepert M, Horn H, et al. Clinical impact of the cell-of-origin classification and the MYC\/ BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the german high-grade non-hodgkin\u2019s lymphoma study group. J Clin Oncol. 2017;35:2515\u201326.","journal-title":"J Clin Oncol"},{"key":"3781_CR58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"issue":"551\u201368","key":"3781_CR59","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, et al. a probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(551\u201368): e14.","journal-title":"Cancer Cell"},{"key":"3781_CR60","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/his.14594","volume":"80","author":"KN Naresh","year":"2022","unstructured":"Naresh KN, Lazzi S, Santi R, Granai M, Onyango N, Leoncini L. A refined approach to the diagnosis of Burkitt lymphoma in a resource-poor setting. Histopathology. 2022;80:743\u20135.","journal-title":"Histopathology"},{"key":"3781_CR61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2016-12-759621","volume":"130","author":"N Tsuyama","year":"2017","unstructured":"Tsuyama N, Sakata S, Baba S, et al. BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation. Blood. 2017;130:489\u2013500.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03781-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03781-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03781-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:42:26Z","timestamp":1740469346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03781-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3781"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03781-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}